* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Genetic Testing - Richard MacMinn
Gene expression programming wikipedia , lookup
Polymorphism (biology) wikipedia , lookup
Genetically modified food wikipedia , lookup
Gene therapy wikipedia , lookup
Koinophilia wikipedia , lookup
Quantitative trait locus wikipedia , lookup
Human genome wikipedia , lookup
Whole genome sequencing wikipedia , lookup
DNA paternity testing wikipedia , lookup
Site-specific recombinase technology wikipedia , lookup
Genetic code wikipedia , lookup
Genetic drift wikipedia , lookup
Pharmacogenomics wikipedia , lookup
Genome editing wikipedia , lookup
Human Genome Project wikipedia , lookup
Heritability of IQ wikipedia , lookup
Genome evolution wikipedia , lookup
Behavioural genetics wikipedia , lookup
Medical genetics wikipedia , lookup
Designer baby wikipedia , lookup
Population genetics wikipedia , lookup
History of genetic engineering wikipedia , lookup
Genetic engineering wikipedia , lookup
Microevolution wikipedia , lookup
Human genetic variation wikipedia , lookup
Genetic engineering in science fiction wikipedia , lookup
Genetic testing wikipedia , lookup
Genetic Testing and Adverse Selection Richard D. MacMinn Illinois State University and Patrick L. Brockett University of Texas Asia-Pacific Risk and Insurance Association Bangkok July 2003 American Risk and Insurance Association Denver August 2003 European Group of Risk and Insurance Economists Zurich September 2003 Timeline The initial planning process culminated in 1990 with the publication of a joint research plan, "Understanding Our Genetic Inheritance: The U.S. Human Genome Project. The First Five Years FY 1991-1995“ and the 15 year Human Genome Project Began 26 June 2000 - International Human Genome Sequencing Consortium Announces the Working Draft of the Human Genome 15 February 2001 - Complete human genome sequence announced in the two leading scientific journals - Nature (NIH/DOE) and Science (Celera) number Genome Database 900 800 700 600 500 400 300 200 100 0 genes associated with genetic disorders mapped genes 1 3 5 7 9 11 13 chromosome number 15 17 19 21 Y Quotes “Genetic testing has the potential to revolutionize medicine. But revolutions can have casualties.” Francis Collins, Director of the Human Genome Project, Newsweek, 1996 “All progress is precarious, and the solution of one problem brings us face to face with another problem.” Martin Luther King Concerns: Should regulators care? Should insurers be able to underwrite using the results of genetic tests? Under what conditions? Concern about discrimination creating a class of uninsured risks Will there be a repeat of the industry exit such as occurred in Washington DC? Why should insurers care? Why should regulators care? A Texas woman who was turned down for life and disability insurance because her doctor had noted on records that her mother might have died of Huntington's disease. Her mother, however, had never been diagnosed. Fear of losing insurance In April 1996 two US Marines were court-marshaled and ultimately discharged from the Marines for refusing to provide a DNA sample. The Marines feared that information might leak from the government storehouse and others might eventually be able get access to their genetic sample. They feared that they could experience genetic based discrimination in employment or health insurance after they left the Marines. Example: "discriminating" based on genetic information A California man was denied health insurance when he changed jobs because he had the gene for neurofibromatosis, even though he no signs of the disease. Fear of losing employment Burlington Northern & Santa Fe Railway In a case that sends a strong signal discouraging employers' use of genetic testing, Burlington Northern & Santa Fe Railway Co. agreed to pay $2.2 million to 36 employees to settle a landmark Equal Employment Opportunity Commission lawsuit over the controversial screening. Regulation United Kingdom Europe United States Asia United Kingdom Previously industry was regulated by the ABI code of conduct According to the code, insurers could not require genetic tests. Now there is a five year moratorium “…from 1 November 2001 insurers will not take genetic data into consideration when evaluating premiums unless the government's Genetics and Insurance Committee has approved the test and the policy is a life policy exceeding £500,000 or another policy, for example long-term care cover, exceeding £300,000.” “So far, the only test the committee has approved is for Huntington's disease, but it is also in the process of reviewing whether tests for a hereditary form of Alzheimer's disease, as well as breast and ovarian cancer, can be included.” Europe Council of Europe Convention on Human Rights and Biomedicine (1997) Chapter IV – Human genome Article 11 – Non-discrimination - Any form of discrimination against a person on grounds of his or her genetic heritage is prohibited. Article 12 – Predictive genetic tests - Tests which are predictive of genetic diseases or which serve either to identify the subject as a carrier of a gene responsible for a disease or to detect a genetic predisposition or susceptibility to a disease may be performed only for health purposes or for scientific research linked to health purposes, and subject to appropriate genetic counselling. Europe Legislation prohibiting access Austria (The Gene Technology Act, 1994) Belgium (Law on Terrestrial Insurance Contracts, 1992) Norway (Act Relating to the Application of Biotechnology in Medicine, Law n. 56 of 5 August 1994) Sweden (Law 114 of March 1991 on the Use of Certain Gene Technologies within the Context of General Medical Examinations (1993)) Europe Moratorium prohibiting access France (French Federation of Insurance Companies, 1994, 1999) Germany (German Insurers’ Association, 1999) The Netherlands (Verzekeraars verlengen moratorium erfelijkheidsonderzoek, December 1990 (1995)) Switzerland Europe Voluntary code Finland, Greece, Ireland Other Italy, Portugal Asia China Almost unanimously - by 91% - the scientists said that couples who carried the same disease-causing genetic mutation should not be allowed to have children. United States - Health Early regulation in 1975, 1978, 1982 prohibited denial of health coverage or charging higher premiums for those with the sickle cell trait. 40 of the 50 states have regulations covering genetic testing. The regulations generally prohibit cancelling, limiting, denying or establishing differentials in premium rates based on genetic test results California, New Hampshire and New Jersey prohibit the use of family history in setting rates Concerns Can self-insuring employers limit coverage? Yes Can employer see results of genetic tests? Yes Legislation by year 25 20 15 10 5 0 19 91 19 92 19 93 19 94 19 95 19 96 19 97 19 98 19 99 20 00 20 01 United States - Life Existing state law on life insurance can be categorized as follows: (1) those that require that life insurers obtain the applicants’ informed consent for genetic testing or use of genetic information, e.g., AZ, CA, MA, MN; (2) those that require that life insurers use genetic information only in an actuarially justified manner, e.g., MT, NJ, NM; and (3) proposals to prohibit the use of genetic information altogether or for policies below a certain dollar amount, e.g., AZ, CA, NY, Oregon. Adverse Selection Literature MacDonald, NAAJ, 1999 Subramanian, et. al., JRI, 1999 Lemaire, et. al., NAAJ, 2000 Boyer To insure or not insure Pooling Separating Adverse Selection Market Equilibria Life Health Demand Supply Equilibria Demand Equilibrium Concluding Remarks Is there concern of adverse selection in the insurance industry? -- yes -- “death spiral” concerns -- Are they exaggerated -- possibly Is there a need for regulatory oversight? -- possibly, with restraint and rational approaches that respect market economics Precautionary Quote "Our society went into the age of nuclear energy blindly, and we went into the age of DDT and other pesticides blindly. But we cannot afford to go into the age of genetic engineering blindly. Instead we must move into this exciting new era with an awareness that gene therapy can be used for evil as well as for good. As we reap the benefits of this technology, we must remember its pitfalls and remain vigilant." W. French Anderson, Scientific American, 1995